Lv11
50 积分 2025-07-11 加入
Preclinical and phase I randomized study of a potent inhalable nanobody targeting TSLP for the treatment of airway inflammation
45分钟前
已完结
Abstract 1567: GLR1059, next-generation nectin-4-targeted ADC with a novel mechanism-of-action payload, demonstrated significantly potent anti-tumor efficacy and reduced toxicity in preclinical evaluation
1小时前
已关闭
Gut microbiota in human metabolic health and disease
9个月前
已完结
皖公网安备34019202002308
